For information on the Phasix™ Plug and Patch Click Here.
Phasix™ Mesh is constructed of monofilament
- Fully resorbable monofilament knitted mesh
- Comparable initial strength to traditional polypropylene mesh3
- Gradually degrades over time with minimal resorption throughout the initial 12-26 weeks.4
- Supports repair site up to 12–18 months post implant4
|1 Phasix Mesh Instructions for Use, PK3795413.
2 Martin DP, Williams SF. “Medical Applications of Poly-4-Hydroxybutyrate: A Strong Flexible Absorbable Biomaterial.” Biochemical Engineering Journal. 2003 (16): 97-105.
3 Benchtop test data on file at C. R. Bard, Inc. Results may not correlate to performance in humans.
4 Preclinical data on file at C. R. Bard, Inc. Results may not correlate to performance in humans.
Indications for Use
Phasix™ Mesh is indicated to reinforce soft tissue where weakness exists, such as the repair of hernia or other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Because Phasix™ Mesh is fully resorbable, it should not be used in repairs where permanent wound or organ support from the mesh is required.
The placement of Phasix™ Mesh in direct contact with bowel or viscera is not recommended. The safety and product use for patients with hypersensitivities to tetracycline hydrochloride or kanamycin sulfate is unknown.
Use of this device in patients with known allergies to these antibiotics should be avoided.The safety and effectiveness of Phasix™ Mesh in pediatric use has not been evaluated or established. If an infection develops, treat the infection aggressively. An unresolved infection may require removal of the device.
Possible complications include infection, seroma, pain, mesh migration, wound dehiscence, hemorrhage, adhesions, hematoma, inflammation, extrusion and recurrence of the hernia or soft tissue defect.
Please consult package insert for more detailed safety information and instructions for use.